Dame Sally Davies Chair of AMR Research, Director, Centre of Excellence in Infectious Diseases Res.
University of Liverpool, United Kingdom
Disclosure(s): Antabio: Grant/Research Support; Appili Therapeutics: Advisor/Consultant; BioVersys: Grant/Research Support; Bugworks: Grant/Research Support; Centauri: Advisor/Consultant; F2G: Advisor/Consultant, Grant/Research Support; NAEJA-RGM Pharmaceuticals Inc: Advisor/Consultant, Grant/Research Support; National Institute of Health Research (NIHR).: Co-lead for Infectious Diseases; Pfizer: Advisor/Consultant, Grant/Research Support; Phico Therapeutics: Grant/Research Support; Specialist Advisory Committee for GARDP: Advisor/Consultant; Spero Therapeutics: Advisor/Consultant, Grant/Research Support; The Global Antibiotic Research and Development Partnership (GARDP): Grant/Research Support; VenatoRx: Advisor/Consultant